The Asthma Risk Gene, GSDMB, Promotes Mitochondrial DNA-induced ISGs Expression
Journal of Respiratory Biology and Translational Medicine · 2024
DOI: 10.35534/jrbtm.2024.10005 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Respiratory Biology and Translational Medicine, 2024. Verfasst von Tao Liu und 13 weiteren Autor:innen. Beteiligte Einrichtung: Channing Division of Network Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA. Die Arbeit wurde bisher 10-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS.
Abstract (Originalsprache)
Released mitochondrial DNA (mtDNA) in cells activates cGAS-STING pathway, which induces expression of interferon-stimulated genes (ISGs) and thereby promotes inflammation, as frequently seen in asthmatic airways. However, whether the genetic determinant, Gasdermin B (GSDMB), the most replicated asthma risk gene, regulates this pathway remains unknown. We set out to determine whether and how GSDMB regulates mtDNA-activated cGAS-STING pathway and subsequent ISGs induction in human airway epithelial cells. Using qPCR, ELISA, native polyacrylamide gel electrophoresis, co-immunoprecipitation and immunofluorescence assays, we evaluated the regulation of GSDMB on cGAS-STING pathway in both BEAS-2B cells and primary normal human bronchial epithelial cells (nHBEs). mtDNA was extracted in plasma samples from human asthmatics and the correlation between mtDNA levels and eosinophil counts was analyzed. GSDMB is significantly associated with RANTES expression in asthmatic nasal epithelial brushing samples from the Genes-environments and Admixture in Latino Americans (GALA) II study. Over-expression of GSDMB promotes DNA-induced IFN and ISGs expression in bronchial epithelial BEAS-2B cells and nHBEs. Conversely, knockout of GSDMB led to weakened induction of interferon (IFNs) and ISGs in BEAS-2B cells. Mechanistically, GSDMB interacts with the C-terminus of STING, promoting the translocation of STING to Golgi, leading to the phosphorylation of IRF3 and induction of IFNs and ISGs. mtDNA copy number in serum from asthmatics was significantly correlated with blood eosinophil counts especially in male subjects. GSDMB promotes the activation of mtDNA and poly (dA:dT)-induced activation of cGAS-STING pathway in airway epithelial cells, leading to enhanced induction of ISGs.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Channing Division of Network Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA.
- The Mucosal Immunology and Biology Research Center, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02115, USA.
- Weil Cornell Medical School, Joan and Sanford I. Weill Department of Medicine, New York, NY 10065, USA.
- Division of Pulmonary Medicine, Department of Pediatrics, Boston Children's Hospital and Harvard Medical School, Boston, MA 02115, USA.
Förderung
- NHLBI NIH HHS
Zitieren
APA
Liu, T., Hecker, J., Liu, S., Rui, X., Boyer, N., Wang, J., Yu, Y., Zhang, Y., Mou, H., Gomez-Escobar, L. G., Choi, A. M. K., Raby, B. A., Weiss, S. T., & Zhou, X. (2024). The Asthma Risk Gene, GSDMB, Promotes Mitochondrial DNA-induced ISGs Expression. Journal of Respiratory Biology and Translational Medicine. https://doi.org/10.35534/jrbtm.2024.10005
Vancouver
Liu T, Hecker J, Liu S, Rui X, Boyer N, Wang J, et al. The Asthma Risk Gene, GSDMB, Promotes Mitochondrial DNA-induced ISGs Expression. Journal of Respiratory Biology and Translational Medicine. 2024. doi:10.35534/jrbtm.2024.10005
BibTeX
@article{Liu2024,
author = {Liu, Tao and Hecker, Julian and Liu, Siqi and Rui, Xianliang and Boyer, Nathan and Wang, Jennifer and Yu, Yuzhen and Zhang, Yihan and Mou, Hongmei and Gomez-Escobar, Luis Guillermo and Choi, Augustine M K and Raby, Benjamin A and Weiss, Scott T and Zhou, Xiaobo},
title = {The Asthma Risk Gene, GSDMB, Promotes Mitochondrial DNA-induced ISGs Expression},
journal = {Journal of Respiratory Biology and Translational Medicine},
year = {2024},
doi = {10.35534/jrbtm.2024.10005}
}
EUVIMED